News



03. October 2022

Effectum Medical a supporter of the Swiss healthcare ecosystem

Swiss Healthcare Startups is a non-profit organisation that supports innovative startups that aim to add value to the Swiss healthcare ecosystem. The organisation supports startups by providing meaningful exposure and facilitating access to relevant stakeholders thanks to an exclusive digital directory, an extensive partner network, and by organising some of the most inspiring events in Swiss healthcare.

Healthcare innovation is at the heart of Effectums’s business and as an institutional member of Swiss Healthcare Startups we look forward to supporting the Swiss Healthcare ecosystem.



29. August 2022

ISO 13485 Certificate for In-Vitro Diagnostic products received

In spring, we completed our first IVD audit and our ISO 13485 certificate for In-Vitro Diagnostic products has now arrived! This has been the next important step for us to complete our service offering which now covers In-Vitro diagnostics in addition to Medical Device products and software. We are of course pleased to have received the certificate, but we are equally happy to have team members with a proven track record in diagnostics who can expertly accompany our customer projects.



28. July 2022

Swiss Symposium in Point-of-Care Diagnostics October 20th, 2022

This years POCDx Symposium will take place in Basel and Effectum Medical is honored to be a part of it. In addition to the main symposium there will be a pre-event held on October 19th where Effectum Medical will be speaking about IVDR Requirements for Diagnostic Products – in vitro tests, software, instruments

Registration is now open and you can benefit from early bird rates until August 31st, 2022.

For more details about the symposium and to register please visit the symposium website.



20. June 2022

A warm welcome to Camilla

We are strengthening our IVD and software know-how. And let’s see if Camilla can motivate us to act as a triathlon team once as well.

Since completing her MSc in Infection Biology in 2016, Camilla has worked in various Quality Management roles relating to ISO 13485:2016 and IVDR always with increasing responsibilities and has already led a 5-person team. Camilla generally enjoys training and coaching and has given two seminars on Post-Market Surveillance for IVD at the FHNW Muttenz. In the past, Camilla has collaborated on various digitalization projects which will be a great asset for us. (more…)



02. May 2022

Interview for BioLago

In an interview for BioLago – the health network, our co-founder and CEO Karina Candrian talks about the typical challenges startups are facing when trying to bring a new medical device to market.

Karina for example highlights the importance to think about market access and regulatory issues early on. Ideally as soon as you have a suitable product solution. The intended use and properties of a product determine its classification, which in turn has a significant impact on the approval process, budget and time to market.

Read the interview with Karina (in German) on the BioLago blog.